Population pharmacokinetic analysis of etrolizumab in patients with moderately-to-severely active ulcerative colitis.
Moein A, Lu T, Jönsson S, Ribbing J, Kassir N, Zhang W, Sperinde G, Zhang R, Tang M, Oh YS, Bruno R, Zhu R.
Moein A, et al. Among authors: kassir n.
CPT Pharmacometrics Syst Pharmacol. 2022 Sep;11(9):1244-1255. doi: 10.1002/psp4.12846. Epub 2022 Jul 29.
CPT Pharmacometrics Syst Pharmacol. 2022.
PMID: 35851998
Free PMC article.